Psychosocial Risk Factors in Stroke and Myocardial Infarction

INEqualities in Health Psychosocial Determinants of Neuro and Cardio-V@scuLar Disease: Identification of Novel Levers for Secondary Prevention

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02824107

Acronym

INEV@L

Enrollment

294

Registered

2016-07-06

Start date

2016-02-08

Completion date

2019-08-26

Last updated

2020-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction, Stroke

Brief summary

The aim of this study is to identify groups of subjects at risk of recurrence in secondary prevention based on Psychosocial Factors. The aim is also to propose novel levers to reduce health inequalities in this population so as to develop new prevention strategies for neuro- and cardio-vascular health This study is based on data from questionnaires (Quality of life at work, perceived stress, perceived disease severity) and on behavior indicators (factors related to lifestyle: alcohol, smoking, obesity, sedentarity). Biomarkers of endothelial function (ADMA) will also be assayed. It's an interventional study because of blood sample

Interventions

BIOLOGICALblood sample

BEHAVIORALquestionnaires for psychosocial factors

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

No minimum to 65 Years

Healthy volunteers

Inclusion criteria

* Patients who have provided oral consent to participate * Patients over 18 years * Patients hospitalized for type 1 MI or ischemic stroke/TIA \< 24H after symptom onset * Age \< 65 years * With a professional activity (INSEE definition) at the time of the neuro or cardiovascular event * At least one of the following risk factors: current smoking, obesity (waist circumference \> 88 cm (W)/102 cm (M) or a waist/hip ratio 0.85(W)/0.9(M), sedentarity (physical activity \< 150 min / week), alcohol consumption (\> 3 standard glasses per day for men, \> 2 standard glasses/d for women)

Exclusion criteria

* Adult under guardianship * Patients without national health insurance cover * Pregnant or breast-feeding women * Clinical state making it impossible to use questionnaires or to measure risk factors * Stroke or TIA not related to atheroma or cardioembolism (dissection, hemopathy…) * type \> 1 MI

Design outcomes

Primary

Measure	Time frame
number of psychosocial factors (PSF) on the level of risk for neuro-cardiovascular disease.	through the completion study an average of 6 month

Secondary

Measure	Time frame
study the proportion of diméthyl-arginine asymetrical (ADMA) in patients with PSF	1st day

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026